1. Home
  2. EYPT vs ENR Comparison

EYPT vs ENR Comparison

Compare EYPT & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.85

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$20.10

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ENR
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Machinery/Components
Sector
Industrials
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
EYPT
ENR
Price
$13.85
$20.10
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$31.80
$23.14
AVG Volume (30 Days)
1.5M
966.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
6.48%
EPS Growth
N/A
538.46
EPS
N/A
3.32
Revenue
$7,539,000.00
$2,952,700,000.00
Revenue This Year
N/A
$3.87
Revenue Next Year
$3,115.57
$0.85
P/E Ratio
N/A
$6.23
Revenue Growth
N/A
2.28
52 Week Low
$9.41
$15.75
52 Week High
$19.11
$30.29

Technical Indicators

Market Signals
Indicator
EYPT
ENR
Relative Strength Index (RSI) 53.12 46.46
Support Level $12.01 $19.37
Resistance Level $14.52 $21.13
Average True Range (ATR) 1.06 0.91
MACD 0.05 -0.21
Stochastic Oscillator 34.08 8.06

Price Performance

Historical Comparison
EYPT
ENR

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ENR Energizer Holdings Inc.

Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.

Share on Social Networks: